Table 1 Clinical and Demographic characteristics of the studies assessing serum total testosterone (TT) and luteinizing hormone levels (LH) enrolled in the systematic review and meta-analysis.
Study Author | Year | Study Design | Country | PTS control (n) | PTS covid (n) | PTS moderate (n) | PTS severe (n) | TT control | TT covid | LH control | LH covid |
|---|---|---|---|---|---|---|---|---|---|---|---|
Apaydin | 2021 | Prospective | Turkey | 81 | 54 | 27 | 7.63 | 7.01 | |||
Beltrame | 2022 | Retrospective | Italy | 68 | 56 | 12 | |||||
Camici | 2021 | Retrospective | Italy | 24 | 24 | 24 | 10.41 | 5.23 | |||
Cinislioglu | 2021 | Prospective | Turkey | 92 | 358 | 153 | 205 | 11.94 | 6.21 | 3.75 | 7.3 |
Dhindsa | 2021 | Prospective | USA | 90 | 24 | 66 | 3.48 | ||||
Enikeev | 2022 | Prospective | Russia | 44 | 44 | 44 | 13.5 | 7.3 | 3.08 | 3.34 | |
Ilias | 2021 | Prospective | Greece | 29 | 65 | 55 | 8.53 | ||||
Karkin | 2021 | Prospective | Turkey | 70 | 70 | 48 | 3.46 | 2.97 | |||
Koc | 2021 | Prospective | Turkey | 21 | 21 | 21 | 12.15 | 10.06 | 3 | 3.1 | |
Lanser | 2021 | Retrospective | Austria | 155 | 5.67 | 6.49 | |||||
Ma | 2020 | Prospective | China | 273 | 119 | 103 | 16 | 15.23 | 14.92 | 3.46 | 6.45 |
Okcelik | 2020 | Prospective | Turkey | 20 | 24 | 24 | 11.25 | 12.29 | |||
Rastrelli | 2020 | Prospective | Italy | 31 | 21 | 6 | |||||
Salciccia | 2021 | Prospective | Italy | 29 | 9 | 20 | 16.17 | ||||
Salonia | 2021 | Prospective | Italy | 281 | 286 | 174 | 51 | 10.64 | 2.74 | 4.17 | 4.8 |
Temiz | 2020 | Prospective | Turkey | 10 | 10 | 10 | 10.06 | 3.92 | 4.46 | 2.98 | |
Xu | 2020 | Prospective | China | 22 | 39 | 20 | 19 | 13 | 13.64 | 8.05 | 6 |
Zheng | 2021 | Prospective | China | 61 | 38 | 23 |
